Kindred Healthcare (KND) Receiving Somewhat Positive News Coverage, Analysis Finds

News stories about Kindred Healthcare (NYSE:KND) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Kindred Healthcare earned a media sentiment score of 0.00 on Accern’s scale. Accern also assigned media stories about the health services provider an impact score of 45.7847355330513 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

A number of equities analysts have weighed in on the company. Zacks Investment Research raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. BidaskClub lowered Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Deutsche Bank AG cut their price target on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, August 7th. Bank of America Corporation dropped their price objective on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a report on Thursday, September 21st. Finally, Mizuho reiterated a “neutral” rating and issued a $7.50 price objective (down previously from $8.00) on shares of Kindred Healthcare in a report on Tuesday, October 10th. Six analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $8.75.

Kindred Healthcare (NYSE:KND) traded up 1.68% during mid-day trading on Friday, hitting $6.05. The stock had a trading volume of 679,209 shares. The company has a 50-day moving average of $6.64 and a 200-day moving average of $8.87. Kindred Healthcare has a 12-month low of $5.50 and a 12-month high of $11.90. The stock’s market cap is $526.46 million.

Kindred Healthcare (NYSE:KND) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The company’s revenue was down 4.6% on a year-over-year basis. During the same quarter last year, the business posted $0.38 earnings per share. On average, analysts anticipate that Kindred Healthcare will post $0.22 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/27/kindred-healthcare-knd-receiving-somewhat-favorable-news-coverage-report-shows.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Insider Buying and Selling by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply